Invests in categories: DataEnergyTechHardwareHealthTechMedTechPlatformQuantumSoftwareTechnologyUniversity
Parkwalk is one of the UK’s leading growth fund managers backing world-changing technologies emerging out of UK universities and research institutions with the aim of delivering world-class returns.
We back high potential, hard science technology companies that aim to shape the future by commercialising innovation in sectors of strategic importance to UK Plc, such as AI, big data, life science, materials, cleantech, future of mobility, medtech and quantum computing.
Parkwalk currently has over £250m of assets under management. We have invested in over 100 companies across our managed funds, including funds managed in conjunction with the universities of Oxford, Cambridge and Bristol.
In 2017 Parkwalk joined forces with IP Group plc, a FTSE 250 listed company.
We back high potential, hard science technology companies that aim to shape the future by commercialising innovation in sectors of strategic importance to UK Plc, such as AI, big data, life science, materials, cleantech, future of mobility, medtech and quantum computing.
Parkwalk currently has over £250m of assets under management. We have invested in over 100 companies across our managed funds, including funds managed in conjunction with the universities of Oxford, Cambridge and Bristol.
In 2017 Parkwalk joined forces with IP Group plc, a FTSE 250 listed company.
News
766
Portfolio
195
Persons
29
Mentions
126
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 2009
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A; Series B; Grant
Portfolio 195
Show more
Persons 29
| Date | First Name | Last Name | Title | Location | |||
| - | Neil | Cameron | Investment... | linkedin.c... | - | - | - |
| - | Ian | Broadhurst | Investor D... | linkedin.c... | - | - | - |
| - | Amy | Virdee | Legal Coun... | linkedin.c... | - | a*****e@pa... | - |
| - | Canan | Celikdemir | Compliance... | linkedin.c... | - | c*********... | - |
| - | Claire | Pardo | General Co... | linkedin.c... | - | - | - |
| - | Chloe | Woodacre | Head of In... | linkedin.c... | - | - | - |
| - | Wisdom | Yemi-Makan... | Investment... | linkedin.c... | - | - | - |
| - | Emilie | Syed | Investment... | linkedin.c... | - | e***d@park... | - |
| - | Moray | Wright | Chief Exec... | linkedin.c... | - | - | - |
| - | Samiksha | Rai | Investor R... | linkedin.c... | - | - | - |
| - | Cassie | Doherty | Investment... | linkedin.c... | - | - | - |
| - | Olivia | Smith | Investor R... | linkedin.c... | - | - | - |
| - | Enrico | D’Angelo | Chief Fina... | linkedin.c... | - | - | - |
| - | John | Pearson | Investment... | linkedin.c... | - | - | - |
| - | Susie | Harris | Head of Bu... | linkedin.c... | - | - | - |
| - | Barbara | Alku | Investor R... | linkedin.c... | - | b***u@park... | - |
| - | Alastair | Kilgour | Chief Inve... | linkedin.c... | - | - | - |
| - | Harriet | Doherty | Business D... | linkedin.c... | - | - | - |
| - | Martin | Glen | Investment... | linkedin.c... | - | - | - |
| - | Georgia | Docker | Senior Inv... | linkedin.c... | - | i*********... | - |
| - | Steve | Churchhous... | Entreprene... | linkedin.c... | - | - | - |
| - | Charlotte | Burrows | Marketing ... | linkedin.c... | - | c******s@p... | - |
| - | Karolina | Zapadka | Senior Inv... | linkedin.c... | - | k******a@p... | - |
| - | Alun | Williams | Investment... | linkedin.c... | - | - | - |
| - | Kathy | Samii | Chief Oper... | - | - | - | |
| - | Lucy | Allen | Marketing ... | linkedin.c... | - | - | - |
| - | Becky | Amankwah | Investor R... | linkedin.c... | - | - | - |
| - | Gordon | Lawson | Non-Execut... | - | - | - | |
| - | Anne | Dobrée | - | linkedin.c... | - | - | - |
Show more
News 766
| Date | Title | Description |
| 06.01.2026 | Moray Wright features in Professional Adviser | For more than three decades, the Enterprise Investment Scheme has played a significant role in backing founders across the UK. With its expansion at the Budget, it is now positioned to support a far greater number of businesses to scale, no... |
| 09.12.2025 | Parkwalk Knowledge Intensive EIS Fund V – Now Open | We are pleased to announce the launch of the Parkwalk Knowledge Intensive EIS Fund V (KI Fund V), an HMRC-approved EIS Fund. The fifth Knowledge Intensive Fund will back cutting-edge technology companies spun out of leading UK universities,... |
| 23.11.2025 | Parkwalk and IP Group featured in MoneyWeek | Our CEO Moray Wright and IP Group’s CEO Greg Smith sat down with MoneyWeek’s Dr Matthew Partridge to discuss the changing landscape for investing in university spinouts, the role of scale-up capital and the big opportunities for investors. ... |
| 13.11.2025 | Scripta Therapeutics raises $12m | We are pleased to announce our investment in Scripta Therapeutics, a University of Oxford spinout with a novel approach to targeting the aberrant transcriptional networks that drive disease. Oxford, UK: UK techbio startup Scripta Therapeuti... |
| 12.11.2025 | CamGene announces Seed round | We are pleased to announce our investment in CamGene, a University of Cambridge spinout advancing first-in-class RNA-based therapies for hearing loss. Cambridge, UK, 3rd November 2025 – CamGene Therapeutics, a pioneering biotech company adv... |
| 12.11.2025 | Parkwalk named Best EIS Investment Manager 2025 | We’re pleased to announce that Parkwalk was awarded Best EIS Investment Manager at the 2025 Growth Investor Awards. This recognition reflects our ongoing focus and deep expertise in backing university spinouts and helping founders translate... |
| 14.10.2025 | 2025 Beauhurst report on university spinouts | We are delighted to launch our annual report, Equity Investment into University Spinouts 2025, in conjunction with Beauhurst. Download the full report here Tuesday 14 October 2025, London: A new report published today by Parkwalk, the UK’s ... |
| 02.10.2025 | NoBACZ Healthcare announces £4.8m funding round | We are pleased to announce our investment in NoBACZ Healthcare, a University of Cambridge spinout developing innovative “liquid bandage” treatments for horses and livestock. NoBACZ Healthcare, a University of Cambridge spinout developing no... |
| 10.09.2025 | Applied Systems acquires Cytora | We are delighted to report that Applied Systems has acquired portfolio company Cytora, a spinout from the University of Cambridge, who has developed an AI-powered solution for commercial insurance underwriting. Tuesday 9 September – Applied... |
| 02.09.2025 | Phasecraft announce $34m Series B funding round | Parkwalk are pleased to announce further support for portfolio company Phasecraft, the world’s leading quantum algorithms company and a spinout from UCL. Bristol, London, and Washington D.C., 2nd September 2025: Phasecraft, the world’s lead... |
| 28.08.2025 | Moray Wright in Professional Adviser: Pension reform and IHT | This article was originally published by Professional Advisers, written by Parkwalk’s CEO Moray Wright; you can read the full article here. ‘As pensions lose some of their tax advantages, EIS is coming to the fore in estate planning convers... |
| 05.08.2025 | Opsydia closes pre-Series A funding round | We are pleased to announce our latest investment in Opsydia, a University of Oxford spinout using adaptive optics technology for the direct laser writing of features in transparent materials. Oxford, UK, 31st July 2025 – OPSYDIA Limited, a ... |
| 24.07.2025 | Bitfount raises $8m in Series A funding round | LONDON, UK, July 23, 2025 – Bitfount, the federated AI platform transforming clinical research collaboration, has secured $8 million in Series A funding to scale its privacy-preserving network across healthcare systems globally. Parkwalk Ad... |
| 23.07.2025 | Mind Foundry features in Tech Funding News | We’re pleased to see Parkwalk portfolio company Mind Foundry featured in a recent Tech Funding News article spotlighting standout AI startups across the UK and EU that are backed by leading technology investors. A spinout from the Universit... |
| 17.07.2025 | Semarion secures £2.0m in latest funding round | We’re pleased to share that Parkwalk has participated in a £2.0m funding round for Semarion, a spin-out from the University of Cambridge’s Cavendish Laboratory. Semarion is commercialising its SemaCyte® platform, which transforms in-vitro c... |
| 16.07.2025 | Opsydia secures £2.5m in Seed funding round | We are pleased to have invested in Opsydia, a University of Oxford spinout and specialist laser technology company which utilises decades of academic excellence and experience in adaptive optic beam shaping for writing features and function... |
| 27.06.2025 | Ceryx Medical secures £5m in latest funding round | We are pleased to announce our latest investment in Ceryx Medical, a University of Bristol spinout working on revolutionary new pacemaker technology, aimed at helping patients with long-term heart failure. The business has successfully comp... |
| 27.06.2025 | Parkwalk and Northern Gritstone launch Northern Universities Venture Fund | We are delighted to announce the launch of the Northern Universities Venture Fund, in collaboration with Northern Gritstone, offering access to world-class university spinouts and deep science startups from the Northern Arc Universities of ... |
| 27.06.2025 | EIS Case Study – CGT Deferral | The case study below demonstrates how EIS can be used for CGT deferral, income tax relief and inheritance planning, particularly when applied as part of a rolling, long-term strategy. Without EIS investment, a client selling a share portfol... |
| 05.06.2025 | AccelerComm secures $15m funding | We are pleased to announce our latest investment in AccelerComm, a University of Southampton spinout delivering high-performance 5G technology for Satellite networks. Southampton, UK: June 2nd 2025 – AccelerComm, the company delivering high... |
| 05.06.2025 | Parkwalk Investment Directors feature in Tech Funding News | Parkwalk is pleased to be featured in Tech Funding News in an article exploring the sharp rise in venture capital investment across Cambridge, which reached a record $2.3 billion. Our Investment Directors Anne Dobrée and Karolina Zapadka co... |
| 14.05.2025 | EIS Loss Relief Explained: An Element of Downside Protection | The Enterprise Investment Scheme (EIS) offers investors an additional relief that sets it apart from many other investment strategies. Loss relief provides a crucial mechanism that can significantly reduce the potential downside of investin... |
| 03.05.2025 | Parkwalk named top investor in UK university spinouts – Spotlight on Spinouts 2025 | Parkwalk is delighted to have been named the top investor in UK university spinouts by both deal count and value, in a recent report by the Royal Academy of Engineering and Beauhurst, Spotlight on Spinouts 2025. The report highlights the st... |
| 03.05.2025 | What is the Enterprise Investment Scheme (EIS)? | The Enterprise Investment Scheme (EIS) is a UK government initiative designed to encourage private investment in early-stage, innovative companies. The government offers significant tax incentives to investors, supporting the growth of smal... |
| 03.05.2025 | Parkwalk features in the EIS & SEIS Annual Report 2025 | The EIS & SEIS Annual Report 2025 has been released as part of the annual Tax Efficient Investment Report series by IFA Magazine and GBI Magazine. This highly regarded report provides a comprehensive analysis of the Enterprise Investmen... |
| 03.05.2025 | Parkwalk invests in Cambridge Touch Technologies | We are pleased to announce our latest investment in Cambridge Touch Technologies, a University of Cambridge spinout specialising in touch and force-sending technologies, as part of a Series C funding round. Cambridge Touch Technologies (CTT... |
| 03.05.2025 | University of Cambridge Enterprise Fund X – Now Closed | We are delighted to report that the University of Cambridge Enterprise Fund X, in collaboration with Cambridge Enterprise, has now reached full capacity ahead of target, and we will no longer be accepting applications. The Fund was oversubs... |
| 03.05.2025 | Why Invest in University Spinouts? | Anne Dobrée, Investment Director at Parkwalk Advisors, recently joined Jonathan Moyes from Wealth Club to discuss all things EIS and university spinout investing. With her extensive experience, including her tenure as Head of Ventures at th... |
| 03.05.2025 | Tax relief under the Enterprise Investment Scheme (EIS) | Applying for tax relief under the Enterprise Investment Scheme (EIS) can seem complex, but with the right approach and understanding, investors can successfully navigate the process and benefit from significant tax advantages. Before diving... |
| 03.05.2025 | Cutting your 2024 tax bill and investing in Britain’s next billion-pound startup | As we approach Tax Year end, there has never been a more compelling time to understand the value of the Enterprise Investment Scheme (EIS). The scheme offers investors early access to some of the brightest innovation in the UK. This article... |
| 03.05.2025 | Parkwalk’s Moray Wright in The Telegraph | Parkwalk’s CEO Moray Wright recently spoke with The Telegraph on how Britain can take inspiration from the US by investing more in technology to drive economic growth. While the US is positioned at the centre of the coming AI boom and is ho... |
| 03.05.2025 | Supporting Form The Future’s Cambridge Unlocked Initiative | At Parkwalk, we are proud to celebrate International Women and Girls in Science Day by taking meaningful action to support the next generation of female innovators. This year, we are delighted to partner with Form The Future‘s Cambridge Unl... |
| 03.05.2025 | A Complete Guide to EIS Tax Relief | Investing in innovative, early-stage companies becomes significantly more attractive with the Enterprise Investment Scheme (EIS) tax relief. This powerful investment strategy offers UK investors a unique opportunity to support emerging busi... |
| 03.05.2025 | Brainomix completes £14m Series C funding round | We are pleased to announce our latest investment in Brainomix, a University of Oxford spinout pioneering AI-powered imaging tools in stroke and lung fibrosis, as part of a £14m Series C funding round. The funding will support commercial exp... |
| 03.05.2025 | Founders at University of Cambridge: START Accelerator Cohort 2.0 | Parkwalk is delighted to support the START Accelerator 2.0, led by Founders at the University of Cambridge, as it helps early-stage deep tech companies navigate the path from lab to market. Cambridge, UK, 27 March 2025: Founders at the Univ... |
| 03.05.2025 | What is a Knowledge Intensive company? | Knowledge intensive companies are important because they fuel innovation, help develop new technologies and tend to lead to economic growth. Many of these companies have a unique approach to creating value, primarily through intellectual ex... |
| 03.05.2025 | Why invest in university spinouts: Unlocking innovative investment potential | University spinouts represent one of the most exciting and unique investment opportunities in the modern innovation landscape. These companies emerge directly from academic research, bridging the critical gap between groundbreaking scientif... |
| 03.05.2025 | Cambridge GaN Devices – Closes $32m Series C funding round | We are pleased to announce our latest investment in Cambridge GaN Devices (CGD), a University of Cambridge spinout developing energy-efficient semiconductors using gallium nitride (GaN), reshaping the future of power electronics. CGD’s tech... |
| 24.01.2025 | Obituary – Enrico D’Angelo | It is with profound sadness that we announce the passing of our beloved colleague and friend, Enrico D’Angelo. Enrico was instrumental in shaping Parkwalk’s success from its earliest days. His encyclopaedic knowledge of EIS and sharp financ... |
| 23.01.2025 | 100 fastest-growing tech companies in Britain revealed – The Times | The Times’ 100 fastest-growing tech companies list, in partnership with Beauhurst, features four Parkwalk portfolio companies – Evolito Ltd, Mind Foundry, BibliU and Symetrica. Nu Quantum and Xampla were also listed as female-led companies ... |
| 09.01.2025 | Quantum Motion – partners with GlobalFoundries | Portfolio company Quantum Motion recently announced record integration of quantum devices and a partnership with semiconductor manufacturer, GlobalFoundries. The company’s commercial silicon production addresses the need for scalability as ... |
| 30.12.2024 | M-Spin – Closes £1.2m seed round | We are pleased to announce our investment in M-Spin, a spinout from Imperial College London developing a method of manufacturing metallic and ceramic mats with up to 1,000 times greater surface area versus competing technologies. London, UK... |
| 30.12.2024 | Psyomics – raises £4m for mental health tech | We are delighted to announce our latest investment in Psyomics, as part of a £4m funding round. The fresh funding will help accelerate the extension of the company’s AI-informed medical device Censeo, to include specialist children and youn... |
| 30.12.2024 | OW Smell Made Digital – raises £2.2m | We are delighted to announce a further investment in OW Smell Made Digital (OW) as part of a £2.2 million pre-series A funding round. University spinout OW has developed proprietary technology to redefine the way humans experience smell. OW... |
| 30.12.2024 | Molyon – Raises $4.6m for future of sustainable batteries | We are pleased to announce our investment in Molyon, a University of Cambridge spinout specialising in high-energy-density lithium-sulfur (Li-S) batteries with improved performance, more earth-abundant materials and resilient supply chains.... |
| 30.12.2024 | Illumion – Closes £2.1m Seed round | We are pleased to announce our investment in Illumion as part of the University of Cambridge Enterprise Fund X, a University of Cambridge spinout who is commercialising a revolutionary microscope technology known as Charge Photometry. Londo... |
| 30.12.2024 | MintNeuro – Secures £1m investment in latest capital raise | We are delighted to announce our investment in MintNeuro, an Imperial College London spinout and innovative startup at the dynamic intersection of neurotechnology and semiconductors. London, UK, November 12 2024 – MintNeuro, a pioneer of sc... |
| 30.12.2024 | 2024 Beauhurst report on university spinouts | Parkwalk have launched the annual ‘Equity Investments into Spinouts’ 2024 report, in conjunction with Beauhurst. The report findings are also featured in The Times article “Investment in university spin-outs revives after a tough period”. D... |
| 30.12.2024 | University of Cambridge Enterprise Fund X launch | We are delighted to announce the launch of our University of Cambridge Enterprise Fund (UCEF) X. The Fund is managed by Parkwalk in conjunction with Cambridge Enterprise, the university’s research commercialisation arm, backing the very be... |
| 30.12.2024 | DeepForm – raises £2m for car manufacturing tech | We are delighted to announce our investment in DeepForm, as part of a £2m funding round. DeepForm’s novel solution can reduce material waste in car manufacturing by over 75%, as well as helping manufacturers reduce CO2 emissions. London, Ju... |
| 30.12.2024 | Diffblue – secures $6.3m in funding | We are delighted to announce our investment in Diffblue, an Oxford University spinout and creators of the world’s first fully autonomous generative AI-for-code software. Oxford, United Kingdom, October 30 2024 – Diffblue, creators of the wo... |
| 30.12.2024 | PervasID – secures £3.25m to accelerate growth | We are pleased to announce our latest investment in PervasID, a spinout from the University of Cambridge which provides unique, passive radio frequency identification (RFID) solutions with unrivalled detection capability and enables sophist... |
| 30.12.2024 | Ceryx Medical – First-in-human study of Cysoni™ RSA Pacemaker | Cardiff, UK, November 20th 2024 – Ceryx today announced that the first patient has been enrolled in the RSA-Pace multi-center study at Waikato Hospital in Hamilton, New Zealand. The study is designed to evaluate the safety of the Cysoni tem... |
| 30.12.2024 | Wave Photonics – secures £4.5m for light-based chips | We are delighted to announce our investment in Wave Photonics as part of a £4.5m funding round, by our University of Cambridge Enterprise Funds. Wave Photonics develop on-chip photonics designs for quantum technologies, sensors, and datacen... |
| 30.12.2024 | Ikarovec – seed funding round closes at £8m | We are delighted to announce our investment in Ikarovec as part of their seed funding round. Ikarovec is a biotech gene therapy company with a focus on ophthalmology. Norwich, UK, October 2024 – Ikarovec, which is developing novel bicistron... |
| 30.12.2024 | Evoralis – Secures £2.5M to solve enzymatic recycling for textiles | We are delighted to announce our investment in Evoralis, a pioneering company specialising in the discovery and development of plastic-depolymerizing enzymes. Soon to be sitting within Parkwalk’s University of Cambridge Enterprise Fund IX (... |
| 30.12.2024 | Parkwalk – Acquisition of Versed AI | We are delighted to announce the acquisition of portfolio company Versed AI by US supply chain and third-party risk AI company Exiger, resulting in a positive exit for Parkwalk investors. Versed AI is a spinout from the University of Cambri... |
| 30.12.2024 | Cambridge Electric Cement – raises £2.25m | We are delighted to announce our investment in Cambridge Electric Cement as part of a £2.25m seed funding round, by our University of Cambridge Enterprise Funds. Cambridge Electric Cement (CEC), a sustainable cement spin-out from the Univer... |
| 30.12.2024 | PhoreMost – extends Series B to $50m | We are delighted to announce a further investment in PhoreMost, a leading UK biopharmaceutical company unlocking the next generation of drug targets. The University of Cambridge spin-out will use the investment to advance high-value oncolog... |
| 30.12.2024 | DefiniGEN – closes series B funding round | We are delighted to announce our investment in DefiniGEN as part of a Series B funding round. DefiniGEN is shaping the future of liver research and toxicology, through highly predictive in vitro modelling. London, 26th September 2024 – Park... |
| 30.12.2024 | Growth Investor of the Year 2024 Winner | We are delighted to announce that Parkwalk was announced Growth Investor of the Year at the 2024 Growth Investor Awards! It was a fantastic event celebrating the incredible achievements of companies and individuals driving innovation and gr... |
| 30.12.2024 | Knowledge Intensive EIS Fund IV launch | We are pleased to announce the launch of the Parkwalk Knowledge Intensive EIS Fund IV, an HMRC-approved EIS Fund. The fourth Knowledge Intensive Fund will back cutting-edge technology companies spun out of leading UK universities and resea... |
| 30.12.2024 | Universities & investors launch blueprint for boosting UK software spin-outs | UK universities and investors have joined forces to boost the number of software spin-outs from academic innovations by recommending a more efficient deal-making processes designed for rapid scaling. TenU – which represents world-leading un... |
| 21.05.2024 | Oxford Endovascular – raises £8m to tackle brain aneurysms | Delighted to announce our latest investment in Oxford Endovascular, a spin-out from Oxford University, working to prevent brain haemorrhage by treating brain aneurysms, a condition that affects 1 in 50 persons. The investment was featured i... |
| 07.05.2024 | Parkwalk – EIS explained: what is the Enterprise Investment Scheme? Conclusion | The Enterprise Investment Scheme (EIS) is a useful tax planning tool for investors to take advantage of 5 generous tax benefits*, as well as investing in some of the brightest minds and world-changing innovations in the UK. Our CEO, Moray W... |
| 07.05.2024 | Parkwalk Portfolio Showcase 2024 | On Wednesday, 1st May 2024, we held our annual Parkwalk Portfolio Showcase at the Royal Society of Chemistry. The showcase highlighted some of the world-changing innovations we have invested in, which have all benefited from funding from th... |
| 07.05.2024 | Parkwalk – Investing in EIS before Tax Year End | As we approach Tax Year end, there has never been a more compelling time to understand the value of the Enterprise Investment Scheme (EIS). Our CEO, Moray Wright, and Professional Adviser, sheds light on how EIS is making a significant impa... |
| 14.03.2024 | Parkwalk – ‘Founders at the University of Cambridge’ announces first cohort for Start Accelerator programme | From waste plastic transformation to a smart fitness device for the brain, the Founders at the University of Cambridge Start 1.0 accelerator has announced 11 start-ups selected for the programme. As an Investment Partner, we are delighted t... |
| 08.03.2024 | Parkwalk – John Pearson appointed Chief Investment Officer | After fifteen years at the helm of Parkwalk, Alastair Kilgour has decided to step back from being Chief Investment Officer with effect from the end of December 2023. He will, of course, remain a Founder of Parkwalk and will spend several mo... |
| 08.03.2024 | Parkwalk x IP Group – International Women’s Day 2024 panel | On the 6th of March 2024, Parkwalk and IP Group’s Women’s Networking Group hosted a panel discussion at their offices to celebrate International Women’s Day (IWD), with the IWD 2024 theme of ‘inspire inclusion’, and the next generation of f... |
| 28.02.2024 | Parkwalk – Moray Wright, CEO, speaks to IFA Magazine | In a recent interview with IFA/GBI magazine, Parkwalk CEO Moray Wright discusses the most significant growth opportunities for investment, the most common risks for investors and explains Parkwalk’s investment strategy. Read the full interv... |
| 26.02.2024 | adsilico – raises £3.5m funding round | Delighted to announce our investment into adsilico as part of a £3.5m seed funding round, as seen in The Times today. The University of Leeds spin-out is a ground-breaking computational medicine company, developing an end-to-end in-silico t... |
| 21.02.2024 | Echopoint Medical – raises £4.2m in series A funding round | Thrilled to announce our latest investment into Echopoint Medical as part of a £4.2m series A funding round. The University College London spin-out has designed an advanced diagnostic solution for cardiovascular care to improve patient outc... |
| 24.01.2024 | Parkwalk – Imperial College Enterprise Fund III launch | We are delighted to announce the launch of our Imperial College Enterprise Fund (ICEF) III. The Fund is managed by Parkwalk in conjunction with Imperial Enterprise. The Fund invests in early-stage hard science and disruptive technology com... |
| 24.01.2024 | Wayland Additive – raises £4.2m in latest funding round | Thrilled to announce our latest investment into Wayland Additive as part of a £4.2m funding round. Wayland is a Huddersfield-based company providing electron beam, 3D printing technology using Calibur3 metal additive manufacturing (AM) mach... |
| 24.11.2023 | Parkwalk – ‘Best EIS Investment Manager’ at the Growth Investor Awards 2023 | Parkwalk are thrilled to have won ‘Best EIS Investment Manager’ at the Growth Investor Awards 2023, for the second year running. The judges recognised our returns to our investors and our unique strategy investing into cutting-edge technolo... |
| 21.11.2023 | Parkwalk supports ‘Founders at the University of Cambridge’ pre-seed accelerator | Along with 100 experts from Graphcore, Arm, Google and Stripe, we are proud to support the Founders at the University of Cambridge, with Cambridge Enterprise, aiding the next generation of start-ups. This new initiative is the first pre-see... |
| 12.11.2023 | Parkwalk – launches Knowledge Intensive EIS Fund III | We are pleased to announce the launch of the Parkwalk Knowledge Intensive EIS Fund III, an HMRC-approved EIS Fund. As featured in Investment Week, the third Knowledge Intensive Fund will back cutting-edge technology companies spun out of le... |
| 04.11.2023 | Parkwalk – University of Oxford Innovation Fund VI is now closed | We are delighted to announce that our University of Oxford Innovation Fund VI is now closed, surpassing its target and raising £3m. As featured in an article by UKTN, the Fund is run in conjunction with Oxford University Innovation, backing... |
| 27.10.2023 | Phasecraft – raises £13m in Series A Funding Round | We are delighted to announce our latest investment into Phasecraft as part of a £13m Series A Funding Round. The University College London spin-out designs quantum software for quantum information processors encompassing both near-term inte... |
| 27.10.2023 | Parkwalk – 2023 Beauhurst report on university spinouts | Parkwalk have launched our annual ‘Equity Investments into Spinouts’ 2023 report, in conjunction with Beauhurst. The report findings also feature in the Financial Times, “Investment in UK university spinouts falls after decade of growth“ ar... |
| 27.10.2023 | Mogrify – extends Series A financing to $46m USD | Parkwalk is pleased to announce that portfolio company, Mogrify, have extended their Series A financing to $46m USD. The University of Cambridge and University of Bristol spinout is enabling the next generation of gene sequencing and gene-r... |
| 27.10.2023 | Parkwalk – Acquisition of PetMedix | Parkwalk are delighted to announce the acquisition of our portfolio company PetMedix, generating a positive return for our EIS investors. |
| 18.08.2023 | Entia – raises $20m in Series A funding round | Parkwalk is thrilled to announce our latest investment into Entia as part of a $20m series A funding round to launch the world’s most comprehensive monitoring solution for patients undergoing cancer therapy. |
| 27.06.2023 | Parkwalk – University of Oxford Innovation Fund VI launch | We are delighted to announce the launch of our University of Oxford Innovation Fund (UOIF) VI. The fund is managed by Parkwalk, in conjunction with the University of Oxford’s Technology Transfer Office, Oxford University Innovation. The Fun... |
| 08.06.2023 | Parkwalk – Portfolio Showcase 2023 | On Wednesday 7th June 2023, we held our annual Portfolio Showcase at the Royal Society of Chemistry, showcasing innovative companies from our portfolio. |
| 03.06.2023 | OXA – Oxbotica unveils a new brand, as the company scales globally | Parkwalk is delighted to announce Oxbotica’s rebranding to Oxa, marking the next stage in the company’s growth as it prepares to scale in North America and Europe. Oxa has developed autonomous vehicle software that operates anywhere without... |
| 11.05.2023 | AccelerComm – raises £21.5m in Series B Funding Round | Parkwalk announces our recent funding round into new portfolio company AccelerComm. The University of Southampton spin-out has developed patented communication algorithms for 5G, doubling network capacity whilst halving power consumption an... |
| 02.05.2023 | Paragraf – Acquires Cardea Bio, Extending Graphene Electronics Industry Leadership | Parkwalk is delighted to announce that, in a first for the graphene electronics industry, leading integrated device manufacturer Paragraf is acquiring graphene biosensor market pioneer Cardea Bio to accelerate the mass production of a new g... |
| 28.04.2023 | Wayland Additive – raises £4.6m in latest funding round | We are delighted to announce our latest investment into Wayland Additive, as part of a £4.6m funding round. This latest investment will increase Wayland’s in-house production capability delivering more machines and materials to its customer... |
| 30.03.2023 | Parkwalk – Investing in the Science and Technology of Tomorrow | Thrilled to see our CEO, Moray Wright, featured in Business Weekly’s article, discussing technology funding and the UK’s economic ecosystems, especially pension funds. The government’s aim to develop the UK into a science superpower is focu... |
| 21.03.2023 | Parkwalk – Improving Healthcare by Investing in Genomics | To mark the end of Healthcare Science Week, we discuss the value and impact of investing in genomics. We also give examples of some ground-breaking genomic companies Parkwalk has invested in. |
| 14.03.2023 | Legislate raises $3.6m in latest funding round | We are thrilled to announce our recent investment in Legislate, as part of a $3.6m funding round. The University of Oxford spin-out has designed a legal SaaS platform that enables small businesses and landlords to easily create, sign, and m... |
| 09.03.2023 | Parkwalk celebrates International Women’s Day 2023: breaking down gender inequality | To celebrate International Women’s Day 2023, we wanted to recognise the amazing women who work at Parkwalk and the women founders and innovators behind some of our portfolio companies. |
| 01.03.2023 | Quantum Motion Technologies – largest funding round in UK quantum computing | We are thrilled to announce our latest investment into Quantum Motion Technologies as part of a £42m funding round, the largest funding round in UK quantum computing. The University of Oxford spin-out is developing a revolutionary technolog... |
| 01.03.2023 | Parkwalk – Meet the Portfolio series | As part of our annual Portfolio Showcase in 2022, we had the opportunity to sit down with some of our portfolio companies to speak to them about their experiences. We have showcased these in our ‘Meet the Portfolio’ series of videos below.... |
| 09.02.2023 | Parkwalk – International Day of Women and Girls in Science | Parkwalk is delighted to celebrate International Day of Women and Girls in Science 2023. This year we focus on the endless opportunities STEM opens for women and girls, around the globe. |
| 12.01.2023 | Parkwalk – 2022 in numbers | 2022 was another eventful year, especially with the global economic, political and social situation. Despite the turbulence of 2022, Parkwalk has seen yet another successful and busy year. We want to take this time to wish a Happy New Year ... |
| 01.01.2023 | Parkwalk – Merry Christmas and a Happy New Year | We’d like to wish everyone a Merry Christmas and a Happy New Year from everyone at Parkwalk. |
| 23.12.2022 | Qkine – raises £4.3m in latest funding round | We’re delighted to announce our recent investment in Qkine, as part of a £4.3m funding round. The University of Cambridge spin-out has designed a proprietary refolding technology and protein purification technique to produce high quality gr... |
Show more
Mentions in press and media 126
| Date | Title | Description |
| 29.07.2026 | Moa Technology Secures $29.6M, Redefines Global Weed Control | Moa Technology, a UK innovator, secured a $29.6 million Series C round. This funding targets urgent global agricultural challenges. Herbicide-resistant weeds plague farms worldwide. Moa develops revolutionary solutions. It discovers novel m... |
| 23.07.2026 | Moa Technology raises Series C round co-led by Oxford Science Enterprises and Supernova Invest | OXFORD, England, July 23, 2026 /PRNewswire/ -- Moa Technology ("Moa"), an agricultural biotechnology company focused on discovering novel mode of action herbicides, announces a £22.2 million Series C financing round, co-led by Oxf... |
| 21.07.2026 | Mach42 Raises £7 Million To Accelerate AI-Powered Analog Circuit Simulation | Mach42 has raised £7 million in a pre-Series A funding round to accelerate the development and commercial adoption of its AI-powered semiconductor simulation technology. IP Group led the round, with participation from existing investors BGF... |
| 10.07.2026 | Pixel-Flo Fuels MicroLED Revolution with £5.25M Seed Investment | Pixel-Flo, a UK spin-out, landed £5.25 million in seed funding. This investment propels MicroLED display manufacturing forward. Their proprietary Continuous-Flow Mass Transfer technology addresses critical production bottlenecks. Fluidic se... |
| 09.07.2026 | Pixel-Flo Raises £5.25M in Seed Funding | Pixel-Flo team Pixel-Flo, a University of Sheffield (UK) spin-out advancing proprietary Continuous-Flow Mass Transfer technology to address a critical bottleneck in MicroLED display manufacturing, raised £5.25m in Seed funding. The round wa... |
| 09.07.2026 | Pixel-Flo Raises £5.25 Million Seed Round To Scale MicroLED Manufacturing Technology | Pixel-Flo, a University of Sheffield spin-out developing technology to address a major manufacturing bottleneck for MicroLED displays, announced it has raised £5.25 million in Seed funding. The oversubscribed round was led by Northern Grits... |
| 09.07.2026 | Pixel-Flo lands £5.25M seed round for MicroLED manufacturing | Pixel-Flo, a University of Sheffield spin-out developing manufacturing technology for MicroLED displays, has raised £5.25 million in seed funding. The round was led by Northern Gritstone, with participation from SCVC, the Parkwalk Northern ... |
| 07.05.2026 | Quantum Motion Raises $160 Million Series C to Deliver Quantum Computing’s “Transistor Moment” | Quantum Motion, the leading company in silicon transistor-based quantum computing, today announced a $160 million Series C round to commercialise its scalable and energy-efficient approach to quantum computing. The round is co-led by DCVC a... |
| 30.03.2026 | CWOW 2026: Cambridge’s life sciences showcase expands to Oxford & London | Cambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long, interactive festival with Oxford and London for the very first time. The Cambridge-Oxford-London corridor is widely regarded as one of th... |
| 10.03.2026 | Cytotrait Secures £3M: Revolutionizing Crop Traits with MOSS Gene-Editing | Cytotrait, a cutting-edge biotech firm, secured £3M in seed funding. This capital fuels the advancement of their MOSS technology. MOSS is a proprietary plant gene-editing platform. It precisely modifies chloroplasts and mitochondria. This i... |
| 09.03.2026 | Cytotrait Raises £3M in Seed Funding | Cytotrait, a Manchester, UK-based biotechnology company focused on the development of novel traits for food and agriculture, closed £3M seed funding round. The investment was led by Northern Gritstone, with contributions from the UK Innovat... |
| 19.12.2025 | Riverlane unveils microsecond quantum error decoder | - |
| 09.12.2025 | Parkwalk Knowledge Intensive EIS Fund V – Now Open | We are pleased to announce the launch of the Parkwalk Knowledge Intensive EIS Fund V (KI Fund V), an HMRC-approved EIS Fund. The fifth Knowledge Intensive Fund will back cutting-edge technology companies spun out of leading UK universities,... |
| 16.11.2025 | Scripta Therapeutics Transforms Disease Treatment with $12M Investment | Scripta Therapeutics, an Oxford-based techbio startup, has raised $12 million in seed funding. This capital propels its innovative biology-first platform. The system leverages AI, advanced imaging, and patient-derived models. It precisely t... |
| 14.11.2025 | Scripta Therapeutics Raises $12M in Seed Funding | Scripta Therapeutics, an Oxford, UK-based techbio startup, raised $12m in seed funding. The round was led by Oxford Science Enterprises and Apollo Health Ventures, with participation from AlbionVC, YZR Capital, and Parkwalk Advisors, and su... |
| 14.11.2025 | Scripta Therapeutics: $12 Million Closed To Advance Biology-First Drug Discovery Targeting Transcription Factor Activity | Scripta Therapeutics, an Oxford-based techbio startup developing disease-modifying drugs that alter transcription factor activity, has emerged from stealth with the announcement of a $12 million seed round. The financing is co-led by Oxford... |
| 12.11.2025 | The UK’s Scripta Therapeutics raises over €10 million to “flip the script” on drug discovery | Oxford BioTech startup Scripta Therapeutics emerges from stealth today by announcing a €10.3 million ($12 million) Seed round to upend conventional approaches to drug discovery. The round is led jointly by Oxford Science Enterprises (OSE) a... |
| 04.11.2025 | Diffblue’s Latest Innovations in Unit Test Generation Deliver 20x Productivity Advantage Versus AI Coding Assistants | Diffblue today announced the release of the next generation of its flagship product, Diffblue Cover, to address the unmet need for automated, high quality unit test generation at scale. Focused on empowering software development teams to sy... |
| 17.10.2025 | Inside the UK’s innovation surge: record spinout funding, AI initiatives, and academic momentum | Amid record funding and growth, Britain is shaping itself as a top innovation powerhouse – and it’s doing so by reinvesting in an age-old advantage: its universities. This time, however, it’s not just academia leading the charge. A three-pr... |
| 15.10.2025 | UK Spinouts Look to US as Scale-Up Funding Stalls | University spinouts are facing a funding bottleneck, with only a handful of emerging companies across critical sectors like AI, quantum, and biotech raising enough to scale, according to the latest figures from Beauhurst. The analytics firm... |
| 01.10.2025 | Trismik: £2.2 Million Pre-Seed Funding Closed For LLM Evaluation Platform | Trismik, an emerging company in the realm of artificial intelligence (AI), has recently announced the completion of a £2.2 million pre-seed financing round. This funding was led by Twinpath Ventures and included participation from notable i... |
| 30.09.2025 | NoBACZ Healthcare Raises £4.8M in Funding | Cambridge, UK-based NoBACZ Healthcare, a University of Cambridge spinout developing novel products that support how lesions and wounds are treated in livestock and horses, raised £4.8M in funding. The round was led by The Yield Lab, with pa... |
| 29.09.2025 | AI Evaluation Breakthrough: Trismik Secures £2.2M to Revolutionize LLM Testing | Trismik, a Cambridge spin-out, has emerged from stealth. It raised £2.2 million in Pre-Seed funding. The company redefines AI evaluation. It applies psychometric methods, mirroring human IQ testing, to large language models. This innovative... |
| 29.09.2025 | OXCCU Raises $28m in Series B Funding to Scale Sustainable Aviation Fuel from Waste Carbon | Backed by global leaders in aviation, energy, and climate investing, OXCCU strengthens its position as a critical player in the global push for commercially viable sustainable aviation fuel (SAF). Series B investors include IAGi Ventures (t... |
| 25.09.2025 | Trismik Raises £2.2M in Pre-Seed Funding | Trismik, a Cambridge, UK-based company developing a product for AI builders that provides its adaptive evaluation, raised £2.2M in Pre-Seed funding. The round was led by Twinpath Ventures, with participation from Cambridge Enterprise Ventur... |
| 25.09.2025 | Cambridge spin-out Trismik raises £2.2M to redefine AI evaluation | Cambridge University spin-out Trismik has just emerged from stealth with a £2.2 million Pre-Seed round to tackle this very problem and it’s doing so with a science-backed approach borrowed from human IQ testing. At a time when traditional b... |
| 22.09.2025 | Enhanced Genomics Secures $19M for Breakthrough Drug Discovery | Enhanced Genomics, a pioneering UK biotechnology company, recently secured a significant extension to its Series A funding, now totaling USD $19 million. This capital injection propels its mission to revolutionize drug discovery for common,... |
| 17.09.2025 | Enhanced Genomics Extends Series A Funding to USD $19M | Enhanced Genomics, a Cambridge, UK-based biotechnology company developing 3D multi-omics to identify genetically validated drug targets for common diseases, extended its Series A funding to USD$19M. Backers included BGF, Parkwalk and Meltwi... |
| 16.09.2025 | Cambridge’s Enhanced Genomics extends funding to €16 million to drive development of therapeutics pipeline | Enhanced Genomics, a British BioTech company innovating 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced it has completed a financing round, extending its total Seri... |
| 03.09.2025 | Phasecraft Secures $34M: Quantum Computing Nears Real-World Impact | Quantum algorithms leader Phasecraft secured $34 million in Series B funding on September 2, 2025. This significant investment rapidly advances quantum computing from theoretical concepts to practical, real-world applications. Phasecraft ex... |
| 02.09.2025 | Phasecraft Raises $34M in Series B Funding | Phasecraft, a London, UK-based quantum algorithms company, raised $34M in Series B funding. The round was led by Plural, Playground Global, and Novo Holdings with participation from existing investors LocalGlobe, AlbionVC, and Parkwalk Advi... |
| 02.09.2025 | Phasecraft secures $34M to accelerate practical quantum computing solutions Send us a News Tip EXTRACT THE SIGNAL FROM THE NOISE Cookies | Quantum algorithm company Phasecraft Ltd. announced today that it has raised $34 million in new funding to accelerate its work to transform quantum computing’s theoretical promise into practical applications. Founded in 2019, Phasecraft foc... |
| 02.09.2025 | Phasecraft raises $34M to bring quantum computing closer to solving real-world challenges | Quantum algorithms company Phasecraft has raised $34 million in Series B funding to accelerate its breakthrough work and transform quantum computing’s theoretical promise into practical applications. Quantum computing hardware and software ... |
| 02.09.2025 | Phasecraft: $34 Million Series B Raised For Quantum Algorithms Platform | Phasecraft, a force in the field of quantum algorithms, has recently announced the successful completion of a significant $34 million Series B funding round. This remarkable achievement is poised to accelerate the company’s transformative w... |
| 24.07.2025 | Bitfount Secures $8M to Revolutionize Clinical Research with Federated AI | Bitfount secured $8 million in Series A funding. This capital fuels its privacy-preserving federated AI platform. It revolutionizes clinical research collaboration. The technology eliminates raw data sharing. It brings algorithms directly t... |
| 24.07.2025 | Bitfount raises $8m in Series A funding round | LONDON, UK, July 23, 2025 – Bitfount, the federated AI platform transforming clinical research collaboration, has secured $8 million in Series A funding to scale its privacy-preserving network across healthcare systems globally. Parkwalk Ad... |
| 23.07.2025 | London’s Bitfount raises €6.8 million to break down clinical research data silos with federated AI network | HealthTech platform Bitfount, a British federated AI platform innovating clinical research collaboration, has secured €6.8 million in Series A funding to scale its privacy-preserving network across healthcare systems globally. Parkwalk Advi... |
| 23.07.2025 | Bitfount raises $8M to unlock clinical research data with federated AI | London-based Bitfount, the federated AI platform transforming clinical research collaboration, has secured $8 million in Series A funding to scale its privacy-preserving network across healthcare systems globally. Bitfount removes the data-... |
| 20.06.2025 | Northern Gritstone and Parkwalk: A New Dawn for UK Innovation | In the heart of the UK, a new venture is stirring the pot of innovation. Northern Gritstone, a Manchester-based investment firm, has joined forces with Parkwalk Advisors from London. Together, they are launching the Northern Universities Ve... |
| 19.06.2025 | Northern Gritstone and Parkwalk team up for new EIS fund – will it deliver the UK’s first trillion-euro startup? | Manchester-based investment company Northern Gritstone has partnered with London-based Parkwalk Advisors to launch the Northern Universities Venture Fund, an Enterprise Investment Scheme (EIS) fund designed to offer investors early-stage ac... |
| 03.06.2025 | AccelerComm: Pioneering the Future of 5G with Satellite Technology | In a world where connectivity is king, AccelerComm is making waves. The Southampton-based startup has just secured €13.1 million in funding, a significant boost for its mission to deliver universal mobile coverage through satellite-based 5G... |
| 02.06.2025 | British startup AccelerComm secures €13.1 million to help deliver universal mobile coverage | Southampton-based AccelerComm, a company delivering 5G technology for Satellite networks, today announced that it has closed a funding round totalling €13.1 million to accelerate deployments of their 5G satellite communications products and... |
| 07.05.2025 | British compute sector surged ahead in 2024, report shows | The UK’s deeptech ecosystem is positioning itself as Europe's infrastructural base for AI, with the compute sector emerging as a central pillar of national tech strategy. A new report by AlbionVC and data platform Beauhurst reveals that equ... |
| 28.03.2025 | 5 Interesting Startup Deals You May Have Missed In March: Robot Massages, Renting With Pets And Diagnosing Strokes | 3 Shares Email Facebook Twitter LinkedIn This is a monthly column that runs down five interesting startup funding deals every month that may have flown under the radar. Check out our February entry here. Spring has sprung and so have a list... |
| 22.03.2025 | Brainomix: £14 Million (Series C) Closed For Advancing AI Imaging In Healthcare | Brainomix, a company pioneering AI-based imaging tools in stroke and lung fibrosis, announced the completion of a £14 million ($18 million) Series C investment round. The funding round was co-led by prominent healthtech investors that inclu... |
| 21.03.2025 | Brainomix Secures £14M to Revolutionize Stroke and Lung Fibrosis Treatment | In the fast-paced world of healthcare technology, Brainomix is making waves. The Oxford-based company has just raised £14 million in Series C funding. This investment is a lifeline, aimed at expanding its reach into the U.S. market. With a ... |
| 20.03.2025 | Brainomix Raises £14M in Series C Funding | Brainomix, an Oxford, UK-based company providing AI-powered imaging tools in stroke and lung fibrosis, raised £14M in Series C funding. The round was led by co-led by Parkwalk Advisors, and the Boehringer Ingelheim Venture Fund (BIVF), alon... |
| 20.03.2025 | Brainomix secures €16.7 milllion to advance its AI imaging technology in healthcare | Oxford-based Brainomix, a company pioneering AI-powered imaging tools in stroke and lung fibrosis, today announced the completion of a €16.7 million Series C investment round to expand to the U.S. The round is co-led by prominent HealthTech... |
| 24.02.2025 | Cambridge GaN Devices: $32 Million (Series C) Raised For Energy-Efficient Semiconductors | Cambridge GaN Devices (CGD), an innovator in gallium nitride (GaN) power devices, announced it closed a $32 million Series C funding round. The funding round was led by a strategic investor with participation from British Patient Capital an... |
| 19.02.2025 | Cambridge GaN Devices Secures $32M to Power Global Expansion | In a world racing towards energy efficiency, Cambridge GaN Devices (CGD) has emerged as a beacon of innovation. The UK-based company recently secured $32 million in Series C funding, a financial boost that promises to accelerate its growth ... |
| 18.02.2025 | Cambridge GaN Devices secures €30.5 million to drive global growth in power semiconductor industry | Cambridge GaN Devices (CGD), an innovator in gallium nitride (GaN) power devices, has successfully closed a €30.5 million Series C funding round to expand globally and deliver its products to high-power industrial, data centre, and automoti... |
| 15.01.2025 | Fire, Failure, and Funding: The Realities of Building a Startup Brian Mullins shares the driving forces behind his work at Mind Foundry, how to embrace failure, and why success demands resilience and ... | When Brian Mullins took the helm of Mind Foundry, an artificial intelligence (AI) company, he left behind sunny California for the historic halls of Oxford. But for the entrepreneur, leading a spinout from the University of Oxford's AI rese... |
| 15.11.2024 | Guypo's new venture raises $125M, RealWear acquires Almer, and Bek Ventures launches $250M Fund III | This week we tracked more than 95 tech funding deals worth over €1.2 billion, and over 15 exits, M&A transactions, rumours, and related news stories across Europe. In addition to this week's top financials, we've also indexed the most i... |
| 12.11.2024 | Parkwalk Advisors and Cambridge Enterprise launch tenth fund | Parkwalk Advisors, in collaboration with Cambridge Enterprise, has launched its new University of Cambridge Enterprise Fund X (UCEF X). This is the tenth fund dedicated to early-stage science and technology startups started in Cambridge. UC... |
| 06.11.2024 | Diffblue: AI-For-Code Software Company Raises $6.3 Million | Diffblue, a creator of the world’s first fully autonomous generative AI-for-code software, announced it raised $6.3 million in new capital as it reached a record six-month period with 326% net new ARR growth from the previous six months. To... |
| 30.10.2024 | Diffblue raises $6.3M for autonomous AI-powered test generation platform Your vote of support is important to us and it helps us keep the content FREE. One click below supports our mission to provide ... | Diffblue Ltd., the maker of an autonomous generative artificial intelligence code test platform, said today it secured $6.3 million in new funding to build on its differentiated approach to generating unit tests for Java. The new capital ca... |
| 30.10.2024 | Oxford-based Diffblue secures €5.8 million to fuel momentum for generative AI-for-code | Diffblue, creators of the world’s first fully autonomous generative AI-for-code software, announced it has secured €5.8 million in new capital as it reaches a record six-month period with 326% net new ARR growth from the prior six months. T... |
| 30.10.2024 | Diffblue Raises $6.3M in Funding | Diffblue, an Oxford, UK-based creator of autonomous generative AI-for-code software, raised $6.3M in funding. The round was led by IP Group, Parkwalk Advisors, and AlbionVC, with additional participation from Oxford University, and private ... |
| 23.10.2024 | University spinout numbers on the up after universities “drop” stakes | University spinout numbers are on the increase, prompted by universities lowering their stakes in startups, according to the co-founder of a deeptech startup spun out of a UK university. Many in the startup ecoysysem argue that universities... |
| 16.09.2024 | PhoreMost: Biopharmaceutical Drug Target Company Raises $50 Million (Series B) | PhoreMost, a leading UK biopharmaceutical company unlocking the next generation of drug targets, announced it has added $12 million to its Series B financing, bringing the total raised to over $50 million. Parkwalk Advisors led this additio... |
| 16.09.2024 | UK Spinouts Secure Over £1 Billion in H1 2024 | A report published today from Parkwalk, the UK’s biggest investor in university spinouts, has revealed that UK spinout investment is showing signs of recovery following a challenging year in 2023. The report, Equity Investments Into Spinout... |
| 11.09.2024 | PhoreMost raises £33M to advance 'Drugging the Undruggable' research | PhoreMost, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, has completed an oversubscribed £33 million Series B investment round. PhoreMost’s SITESEEKER platform can identify the best new the... |
| 11.09.2024 | PhoreMost Raises $12M in Series B; Extends Round to $50M | PhoreMost Ltd., a Cambridge, UK-based biopharmaceutical company, added USD $12m to its Series B financing, bringing the total raised to over $50m. The additional investment was led by Parkwalk Advisors, with participation from existing inve... |
| 10.09.2024 | PhoreMost and Puraffinity: Two Biotech Innovators Making Waves in Healthcare | In the world of biotechnology, innovation is the lifeblood that fuels progress. Two companies, PhoreMost and Puraffinity, are leading the charge with groundbreaking advancements in drug development and environmental remediation. Both have r... |
| 10.09.2024 | PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes | Investment to enable progression of pipeline of novel degrader assets through pre-clinical development and support further development of GlueSEEKER™ platform Led by Parkwalk Advisors alongside existing investors BGF, Dr Jonathan Milner, Am... |
| 09.08.2024 | The Future of Scent and Drive: UK Startups Pioneering Innovation | In the heart of the UK, two startups are rewriting the rules of technology. OW Smell Made Digital (OW) and Monumo are not just companies; they are harbingers of a new era. One is harnessing the power of scent, while the other is revolutioni... |
| 08.08.2024 | OW secures £2.2M for digital scent production | OW Smell Made Digital (OW) has raised £2.2M in a pre-Series A funding round. Parkwalk Advisors, the UK’s most active investor in university spinouts, led the raise by investing £1.5 million. OW has also been awarded a £0.7 million grant fro... |
| 16.08.2023 | Phasecraft's Quantum Leap: £13M funding for real-world applications | Spun out of University College London and the University of Bristol, quantum tech start-up Phasecraft is in the race to realise the advantages of quantum. Already claiming its quantum algorithms are primed for the imperfect quantum computer... |
| 27.07.2023 | UK-based Entia raises €18.6M to improve the lives of people undergoing cancer treatment | Read this article in: London-based Entia, a healthtech company that claims to transform cancer care to improve the everyday lives of patients undergoing cancer treatment, announced on Wednesday, July 26, that it has secured £16M (nearly €18... |
| 30.06.2023 | UK-based RoboK raises €1.9M, grant to provide safety and efficiency for industrial sites | Cambridge-based RoboK, a startup applying AI-powered computer vision to logistics and industrial workplaces, announced on Friday that it has secured $2.1M (approximately €1.93M) in a fresh round of funding for accelerating commercial expans... |
| 23.06.2023 | Scopri il mercato del Venture Capital a maggio 2023 | Come è andato il mercato del Venture Capital a maggio 2023? Facciamo insieme una carrellata delle startup, delle scaleup e dei round più interessanti, tenendo presente che rispetto allo scorso anno si registra un calo molto significativo. ... |
| 11.05.2023 | AccelerComm’s signal gets supercharged with £21.5 million funding round | Southhampton-based IP company AccelerComm provides solutions which enable optimal performance of 5G radio access networks. It is used to correct mobile transmission errors caused by noise, interference and poor signal strength - popular amo... |
| 19.04.2023 | Wayland Additive raises £4.6 million to increase production of its electron beam 3D printing solution | Huddersfield-based Wayland Additive Limited, an electron beam 3D printing manufacturer has raised £4.6 million in funding to increase its in-house production capability, expand its team and hire a COO. Investing in the round are existing in... |
| 14.03.2023 | Legislate raise $3.6 million to double down on UK sales | UK-based Legislate today announced it has raised $3.6 million in funding for its legal technology company to double down on UK sales and prepare for international expansion this year. The round was round led by Parkwalk Advisors, with parti... |
| 07.11.2022 | Carbon Re raises £4.2m to spot emission inefficiencies using AI | Climate tech startup Carbon Re has raised £4.2m in seed funding for its AI platform that spots inefficiencies in energy-intensive industries to reduce carbon emissions. Founded as a joint spinout of the University of Cambridge and UCL, a ke... |
| 25.07.2022 | UKI2S gets £37m top up to support British energy, defence, biology spinouts | Publicly backed UK Innovation and Science Seed Fund (UKI2S) is expanding its patient capital fund by £37m to support spinouts in fields like synthetic biology, fusion energy and defence. The evergreen fund — one with no set end date, which ... |
| 13.07.2022 | Parkwalk Advisors: Meet the UK’s most active investor in academic spinouts | The UK has a thriving spinout ecosystem. Innovative technologies cultivated in academia have gone on to raise millions in capital and exit in blockbuster IPOs. But who is the most active investor in UK university spinouts? According to a re... |
| 26.05.2022 | The Week in Agrifoodtech: Stable raises $60m, Galley gets $14m, World Bank’s $30bn food crisis response | Multiple restaurant tech companies made headlines this week, from Galley Solutions’ sizeable Series A fundraise to TRAY’s multi-year deal with IHOP. Meanwhile, a carbon initiative in Africa nabbed its first tranche of funding to restore lan... |
| 26.05.2022 | EXCLUSIVE: Moa nets $44m Series B funding to launch the next generation of herbicides | UK-based ag biotech startup Moa Technology has raised £35 million ($44 million) for its latest funding round, AFN can exclusively reveal. It’s aiming to tackle the growing problem of herbicide resistance by taking a new approach to the disc... |
| 11.04.2022 | London’s GripAble gets $11 million to increase its grip on the US market | With many patients being isolated at home and unable to attend therapy appointments owing to the Covid-19 situation, home monitoring health care startups have been getting a lot of attention. While last week, Grenoble-based company CardioRe... |
| 01.03.2022 | Cambridge graphene-based startup rakes in $60 million to rollout biosensor for healthcare industry | Cambridge-based graphene startup Paragraf has raised $60 million funding in a Series B round. The investment was led by US deep tech investor New Science Ventures and saw the participation of Molten Ventures alongside fellow current investo... |
| 22.02.2022 | Addressing foundational bottlenecks in drug discovery, Cambridge spin-out lands £2.14 million | University of Cambridge spin-out company Semarion has raised a £2.14 million seed funding. The round was led by Parkwalk Advisors, with the participation of University of Cambridge Seed Funds, Martlet Capital, and angel investors. The fundi... |
| 18.02.2022 | BGF-backed Bramble Energy secures £35m to support net zero mission | London-based fuel cell company Bramble Energy has closed a £35 million investment round to help further expand its game changing capabilities in solving key challenges in the production and implementation of hydrogen fuel cell stacks. This... |
| 13.12.2021 | Parkwalk launches second HMRC ‘approved’ EIS fund following the success of Fund I | Parkwalk launches second HMRC ‘approved’ EIS fund following the success of Fund I 13-12-2021 Parkwalk, the UK’s most active investor in world changing technologies from UK universities and research institutions, has launched its second Know... |
| 22.07.2021 | Mercedes-Benz acquires Oxford-based electric motor startup YASA | Oxford University spinout electric motor company YASA has been acquired by Mercedes-Benz. The announcement arrives in conjunction with the auto manufacturers’ intention to go all-electric by the end of the decade, with YASA’s technology pla... |
| 04.05.2021 | HexagonFab secures CHF 2.5 million seed round | Alongside Cambridge Enterprise, an international syndicate of investors joined HexagonFab’s seed investment round. Among them are Parkwalk, New Grounds VC, Silicon Valley-based R42 Group, Swiss Health Angels and several private investors. P... |
| 04.05.2021 | Mogrify raises $17m investment led by Parkwalk Advisors | - |
| 04.05.2021 | HexagonFab secures CHF 2.5 million seed round | |
| 11.03.2021 | Oxford-based Legislate Technologies secures £1 million, uses AI to simplify contracts for businesses and landlords | A member of the growing ecosystem of Oxford startups and spinouts, legaltech startup Legislate has secured a £1 million raise. Investors include Parkwalk Advisors via their Opportunities EIS fund, Perivoli Innovations and undisclosed privat... |
| 10.02.2021 | Cambridge launches eighth Enterprise fund | Cambridge launches eighth Enterprise fund 10-02-2021 The University of Cambridge has launched its eighth Enterprise Fund, managed by university spinout fund manager Parkwalk in conjunction with Cambridge Enterprise, the University’s Technol... |
| 03.08.2020 | IP GROUP PLC IP : Bramble Energy Ltd - Secures significant new capital to accelerate its unique fuel cell deployment | Bramble Energy, the world's most scalable hydrogen fuel cell company, has raised a £5m Series A round. BGF led the round and was joined by existing investors including IP Group, Parkwalk Advisors, and UCL Technology Fund. Bramble Energy has... |
| 30.06.2020 | Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion | PharmEnable, a Cambridge-based drug discovery company using advanced medicinal chemistry and AI-enabled approaches to design the next generation of highly complex and specific drug candidate molecules, announces it has closed a £1.8 million... |
| 30.06.2020 | Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion | Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion 30-06-2020 PharmEnable, a Cambridge-based drug discovery company using advanced medicinal chemistry and AI-enabled approaches to design the next generation of highly c... |
| 22.06.2020 | Tech.eu Podcast #174: Wirecard misses billions, EU investigates Apple, and we interview the CEO of Parkwalk | The Tech.eu Podcast is a show in which we discuss some of the most interesting stories from the European technology scene and interview leading entrepreneurs and investors from across the region. This week, we talk about some of the biggest... |
| 08.06.2020 | Qkine secures £1.5M Series A funding from leading life science investors | Qkine secures £1.5M Series A funding from leading life science investors 08-06-2020 Qkine today announced the successful closure of a £1.5M Series A investment round to accelerate the global scale-up of its commercial operations and make ke... |
| 08.06.2020 | Qkine secures £1.5M Series A funding from leading life science investors | Qkine today announced the successful closure of a £1.5M Series A investment round to accelerate the global scale-up of its commercial operations and make key hires to its leadership team. Qkine – a specialist developer and manufacturer of p... |
| 09.03.2020 | London’s Imperial College debuts ‘Innovation Fund’ to back startups founded by students and staff | Imperial College London, one of the world’s leading universities, is today launching its first ‘Innovation Fund’ to back early-stage spin-out startups founded by students or staff, or with a research or development link to the institution. ... |
| 13.02.2020 | Research report on university spinouts shows decline in investment | Research report on university spinouts shows decline in investment 13-02-2020 Equity investment into UK university spinouts declined by nine per cent in 2019, highlighting a crucial funding gap for commercialisation of cutting-edge technolo... |
| 09.01.2020 | UK aeroponics startup LettUs Grow raises £2.35m seed round | LettUs Grow — a UK startup designing aeroponic systems and farm management software for vertical farms, greenhouses and other indoor ag spaces — has secured £2.35 million ($3.1 million) in seed funding. Early-stage life science and engineer... |
| 14.10.2019 | UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon | Cambridge, UK-based biotech startup Mogrify, which is working on systematizing the development of novel cell therapies in areas such as regenerative medicine, has closed an initial $16 million Series A. The raise from investors Ahren Innova... |
Show more